Trial reportJournal of biomedical optics2025
Near-infrared light-induced transcranial photobiomodulation enhances the visual pathway's function in healthy volunteers.
Trial report in Journal of biomedical optics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07736092 (Impact of Perioperative Transcranial Photobiomodulation on Delayed Neurocognitive Recovery in Older Patients After Surgery), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of Perioperative Transcranial Photobiomodulation on Delayed Neurocognitive Recovery in Older Patients After Surgery: a Randomized, Double-blind, Pseudo-modulation-controlled Preliminary Clinical Trial
Who cites it
1 citing paper in PubMed.
- Introduction to Special Issue on Metabolic Imaging and Spectroscopy, 2025.Journal of biomedical optics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Significance: Low-level near-infrared light-induced transcranial photobiomodulation (NIR-TPBM) is a promising technology for improving cerebral blood flow and metabolism. However, the effects of NIR-TPBM on the visual pathway's function remain poorly understood. Aim: The aim was to assess the visual pathway's function changes in response to NIR-TPBM in young, healthy volunteers. Approach: This single-center, randomized, controlled clinical trial included 98 healthy volunteers with a median age of 23.2 years. Participants were randomly assigned to two groups: NIR-TPBM (18 men and 30 women) and sham NIR-TPBM (19 men and 31 women). Eye-tracking procedures were conducted in both groups before and after either PBM or sham intervention. In the NIR-TPBM group, low-fluence NIR-TPBM was applied to the left and right fronto-temporal regions using a NIR-TPBM device (Elmedlife H Results: NIR-TPBM procedures led to a significant increase in both vertical and horizontal VRx values. Post-procedure vertical VRx was significantly higher than pre-procedure values (0.879 [0.761; 0.918] versus 0.774 [0.721; 0.929], Conclusions: NIR-TPBM enhances visual pathways function by increasing both vergence reactivity indices in young healthy volunteers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.